Utility of fine-needle aspiration as a diagnostic technique in lymphoma

Sean T. Hehn, Thomas M. Grogan, Thomas P Miller

Research output: Contribution to journalArticle

165 Citations (Scopus)

Abstract

Purpose: To evaluate, from a clinician's perspective, the sensitivity and specificity of fine-needle aspiration (FNA) as a technique for the diagnosis of lymphoma. Patients and Methods: Medical records of 470 new patients seen in one lymphoma specialist's clinic from January 1998 through December 2002 were reviewed. Ninety-nine (21%) of the 470 patients underwent a total of 115 FNA procedures, which were assessed by more than 70 different pathologists in 32 different pathology departments. Subsequent excisional biopsies were performed in 67 of these patients and interpreted by a single hematopathology group without independent review. Results: Of 115 FNA procedures, 93 were completed for the initial evaluation of lymphoma and 22 were done for assessment of relapsed disease. Of the 93 FNA attempts at initial diagnosis, only 27 (29%) were given a specific and complete histologic diagnosis using an accepted classification system (Working Formulation, Revised European-American Classification of Lymphoid Neoplasms, WHO). For the 22 FNAs done for recurrent disease, only nine (41%) were classified using an accepted system. Sixty-seven (72%) of the 93 FNAs performed for the evaluation of initial disease had subsequent excisional biopsies. Among these paired comparisons, only eight (12%) of 67 FNA diagnoses were correlated with the subsequent excisional biopsy diagnosis. Immunophenotyping was completed on 24 of the 67 paired FNAs. Seven of the 24 FNAs with immunophenotyping (29%) were correlated with subsequent histology on excisional biopsy. Only one (2%) of 43 FNA diagnoses, based on morphology alone, was correlated with subsequent excisional biopsy diagnosis. Conclusion: Overall, FNA for lymphoma diagnosis is not helpful, not cost effective, and in addition may misguide treatment.

Original languageEnglish (US)
Pages (from-to)3046-3052
Number of pages7
JournalJournal of Clinical Oncology
Volume22
Issue number15
DOIs
StatePublished - 2004

Fingerprint

Fine Needle Biopsy
Lymphoma
Biopsy
Immunophenotyping
Matched-Pair Analysis
Medical Records
Histology
Pathology
Costs and Cost Analysis
Sensitivity and Specificity
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Utility of fine-needle aspiration as a diagnostic technique in lymphoma. / Hehn, Sean T.; Grogan, Thomas M.; Miller, Thomas P.

In: Journal of Clinical Oncology, Vol. 22, No. 15, 2004, p. 3046-3052.

Research output: Contribution to journalArticle

Hehn, Sean T. ; Grogan, Thomas M. ; Miller, Thomas P. / Utility of fine-needle aspiration as a diagnostic technique in lymphoma. In: Journal of Clinical Oncology. 2004 ; Vol. 22, No. 15. pp. 3046-3052.
@article{f747a79c8dd14608b738ee58fe588d72,
title = "Utility of fine-needle aspiration as a diagnostic technique in lymphoma",
abstract = "Purpose: To evaluate, from a clinician's perspective, the sensitivity and specificity of fine-needle aspiration (FNA) as a technique for the diagnosis of lymphoma. Patients and Methods: Medical records of 470 new patients seen in one lymphoma specialist's clinic from January 1998 through December 2002 were reviewed. Ninety-nine (21{\%}) of the 470 patients underwent a total of 115 FNA procedures, which were assessed by more than 70 different pathologists in 32 different pathology departments. Subsequent excisional biopsies were performed in 67 of these patients and interpreted by a single hematopathology group without independent review. Results: Of 115 FNA procedures, 93 were completed for the initial evaluation of lymphoma and 22 were done for assessment of relapsed disease. Of the 93 FNA attempts at initial diagnosis, only 27 (29{\%}) were given a specific and complete histologic diagnosis using an accepted classification system (Working Formulation, Revised European-American Classification of Lymphoid Neoplasms, WHO). For the 22 FNAs done for recurrent disease, only nine (41{\%}) were classified using an accepted system. Sixty-seven (72{\%}) of the 93 FNAs performed for the evaluation of initial disease had subsequent excisional biopsies. Among these paired comparisons, only eight (12{\%}) of 67 FNA diagnoses were correlated with the subsequent excisional biopsy diagnosis. Immunophenotyping was completed on 24 of the 67 paired FNAs. Seven of the 24 FNAs with immunophenotyping (29{\%}) were correlated with subsequent histology on excisional biopsy. Only one (2{\%}) of 43 FNA diagnoses, based on morphology alone, was correlated with subsequent excisional biopsy diagnosis. Conclusion: Overall, FNA for lymphoma diagnosis is not helpful, not cost effective, and in addition may misguide treatment.",
author = "Hehn, {Sean T.} and Grogan, {Thomas M.} and Miller, {Thomas P}",
year = "2004",
doi = "10.1200/JCO.2004.02.104",
language = "English (US)",
volume = "22",
pages = "3046--3052",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "15",

}

TY - JOUR

T1 - Utility of fine-needle aspiration as a diagnostic technique in lymphoma

AU - Hehn, Sean T.

AU - Grogan, Thomas M.

AU - Miller, Thomas P

PY - 2004

Y1 - 2004

N2 - Purpose: To evaluate, from a clinician's perspective, the sensitivity and specificity of fine-needle aspiration (FNA) as a technique for the diagnosis of lymphoma. Patients and Methods: Medical records of 470 new patients seen in one lymphoma specialist's clinic from January 1998 through December 2002 were reviewed. Ninety-nine (21%) of the 470 patients underwent a total of 115 FNA procedures, which were assessed by more than 70 different pathologists in 32 different pathology departments. Subsequent excisional biopsies were performed in 67 of these patients and interpreted by a single hematopathology group without independent review. Results: Of 115 FNA procedures, 93 were completed for the initial evaluation of lymphoma and 22 were done for assessment of relapsed disease. Of the 93 FNA attempts at initial diagnosis, only 27 (29%) were given a specific and complete histologic diagnosis using an accepted classification system (Working Formulation, Revised European-American Classification of Lymphoid Neoplasms, WHO). For the 22 FNAs done for recurrent disease, only nine (41%) were classified using an accepted system. Sixty-seven (72%) of the 93 FNAs performed for the evaluation of initial disease had subsequent excisional biopsies. Among these paired comparisons, only eight (12%) of 67 FNA diagnoses were correlated with the subsequent excisional biopsy diagnosis. Immunophenotyping was completed on 24 of the 67 paired FNAs. Seven of the 24 FNAs with immunophenotyping (29%) were correlated with subsequent histology on excisional biopsy. Only one (2%) of 43 FNA diagnoses, based on morphology alone, was correlated with subsequent excisional biopsy diagnosis. Conclusion: Overall, FNA for lymphoma diagnosis is not helpful, not cost effective, and in addition may misguide treatment.

AB - Purpose: To evaluate, from a clinician's perspective, the sensitivity and specificity of fine-needle aspiration (FNA) as a technique for the diagnosis of lymphoma. Patients and Methods: Medical records of 470 new patients seen in one lymphoma specialist's clinic from January 1998 through December 2002 were reviewed. Ninety-nine (21%) of the 470 patients underwent a total of 115 FNA procedures, which were assessed by more than 70 different pathologists in 32 different pathology departments. Subsequent excisional biopsies were performed in 67 of these patients and interpreted by a single hematopathology group without independent review. Results: Of 115 FNA procedures, 93 were completed for the initial evaluation of lymphoma and 22 were done for assessment of relapsed disease. Of the 93 FNA attempts at initial diagnosis, only 27 (29%) were given a specific and complete histologic diagnosis using an accepted classification system (Working Formulation, Revised European-American Classification of Lymphoid Neoplasms, WHO). For the 22 FNAs done for recurrent disease, only nine (41%) were classified using an accepted system. Sixty-seven (72%) of the 93 FNAs performed for the evaluation of initial disease had subsequent excisional biopsies. Among these paired comparisons, only eight (12%) of 67 FNA diagnoses were correlated with the subsequent excisional biopsy diagnosis. Immunophenotyping was completed on 24 of the 67 paired FNAs. Seven of the 24 FNAs with immunophenotyping (29%) were correlated with subsequent histology on excisional biopsy. Only one (2%) of 43 FNA diagnoses, based on morphology alone, was correlated with subsequent excisional biopsy diagnosis. Conclusion: Overall, FNA for lymphoma diagnosis is not helpful, not cost effective, and in addition may misguide treatment.

UR - http://www.scopus.com/inward/record.url?scp=4143102719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143102719&partnerID=8YFLogxK

U2 - 10.1200/JCO.2004.02.104

DO - 10.1200/JCO.2004.02.104

M3 - Article

C2 - 15284254

AN - SCOPUS:4143102719

VL - 22

SP - 3046

EP - 3052

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 15

ER -